Marc Cobo insider trades

Open-market stock purchases and sales by Marc Cobo, Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc, from SEC Form 4 filings since Jun 29, 2020.

Recent trades

DateStockTradeValue
Oct 1, 2026BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)$496
Sep 10, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Sep 10, 2026BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)$1.1K
Sep 10, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Jul 1, 2026BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)$975

Companies traded

  • BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Oct 1, 2026
  • TCDA Tricida, Inc: other filings, last Sep 10, 2020

Get free alerts when Marc Cobo files a new trade →